The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Open-label, phase 1, multicenter study to evaluate the safety and preliminary anti-tumor activity of NT-175 in human leukocyte antigen-a*02:01-positive adult subjects with unresectable, advanced and/or metastatic solid tumors that are positive for the TP53 R175H mutation.
 
Carlos Roberto Becerra
Consulting or Advisory Role - Ipsen; Legend Biotech
 
Mark M. Awad
Consulting or Advisory Role - Affini-T Therapeutics; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Foundation Medicine; Gritstone Bio; Instil Bio; Janssen; Merck; Mirati Therapeutics; Novartis; Pfizer; Regeneron
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation
 
J. Randolph Hecht
Stock and Other Ownership Interests - Actym Therapeutics; Rafael Pharmaceuticals
Consulting or Advisory Role - Astellas Pharma; Corcept Therapeutics; Exelixis; Gilead Sciences; Istari; Notch Therapeutics; Regenacy Pharmaceuticals; Tempus
Research Funding - A2 Biotherapeutics (Inst); Amgen (Inst); ARMO BioSciences (Inst); Astellas Pharma (Inst); Bold Therapeutics (Inst); Camurus (Inst); CG Pharmaceuticals (Inst); Crinetics Pharmaceuticals (Inst); Exelixis (Inst); Gilead Sciences (Inst); Gritstone Bio (Inst); Lilly (Inst); Lyell Immunopharma (Inst); Merck (Inst); Mirati Therapeutics (Inst); NGM Biopharmaceuticals (Inst); Tesaro/GSK (Inst); Tizona Therapeutics, Inc. (Inst); Tizona Therapeutics, Inc. (Inst)
Travel, Accommodations, Expenses - Amgen
 
Andrew Scott Paulson
Employment - Day One Biopharmaceuticals (I)
Stock and Other Ownership Interests - Actinium Pharmaceuticals
Honoraria - Array BioPharma; Cardinal Health; Curio Science
Consulting or Advisory Role - AADi; Advanced Accelerator Applications; Amgen; Array BioPharma; Astellas Pharma; AstraZeneca; Bayer; Bristol Myers Squibb; Eisai; EMD Serono; EMD Serono; Exelixis; Exelixis; Exelixis; Hutchison MediPharma; Incyte; Ipsen; Jazz Pharmaceuticals; Lilly; Mirati Therapeutics; Novartis; Pfizer; QED Therapeutics; Seagen; SERVIER; Stromatis Pharma; Takeda
Speakers' Bureau - Ideo Oncology
Research Funding - AstraZeneca (Inst); Bayer (Inst); BioNTech SE (Inst); bristol myers squibb (Inst); Buzzard Pharmaceuticals; Camurus (Inst); Camurus (Inst); Deciphera (Inst); Exelixis (Inst); G1 Therapeutics (Inst); Gilead Sciences (Inst); Gritstone Bio (Inst); Hutchison MediPharma (Inst); incyte (Inst); Innovative Cellular Therapeutics Co (Inst); Inspirna (Inst); Ipsen (Inst); ITM Oncologics (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Nucana (Inst); Regenxbio (Inst); Relay Therapeutics (Inst); Seagen (Inst); Sotio (Inst); Taiho Pharmaceutical (Inst); Tempus (Inst); TransThera Biosciences (Inst); Zentalis (Inst)
Travel, Accommodations, Expenses - AADi; Camurus; Mirati Therapeutics; Nucana; Pfizer
 
Jennifer Lee
Employment - Neogene Therapeutics
Stock and Other Ownership Interests - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Neogene Therapeutics
 
Gabi Palluconi
Employment - Arrowhead Pharmaceuticals; Arrowhead Pharmaceuticals; Instil bio; Neogene Therapeutics
 
Jaquelin Dalton
Employment - Arch Oncology; Neogene Therapeutics
Stock and Other Ownership Interests - AstraZeneca
Travel, Accommodations, Expenses - Neogene Therapeutics
 
Anuradha Patel
Employment - Neogene Therapeutics
 
Ying Yan
Employment - Neogene Therapeutics, Inc. – An AstraZeneca Group company; Sorrento Therapeutics
Stock and Other Ownership Interests - Sorrento Therapeutics
Travel, Accommodations, Expenses - Neogene Therapeutics, Inc. – An AstraZeneca Group company; Sorrento Therapeutics
 
Arianne Perez
Employment - Neogene Therapeutics
Leadership - Neogene Therapeutics
Stock and Other Ownership Interests - Allogene Therapeutics; Cellectis; Century Therapeutics; Kite, a Gilead company; Neogene Therapeutics
Patents, Royalties, Other Intellectual Property - Patents resulting from work at Kite Pharma and Kite, a Gilead company
Travel, Accommodations, Expenses - Neogene Therapeutics
 
Sunny Xie
Employment - Gilead Sciences; Nektar; Neogene Therapeutics; OncoSec
Stock and Other Ownership Interests - BioNTech SE; Gilead Sciences; Nektar; Novavax; Ultragenyx Pharmaceuticals
Consulting or Advisory Role - Nektar
 
Sarah Cohen
Employment - Neogene Therapeutics
Stock and Other Ownership Interests - Crispr Therapeutics; Neogene Therapeutics
Patents, Royalties, Other Intellectual Property - Crispr Therapeutics
Travel, Accommodations, Expenses - Crispr Therapeutics; eogene Therapeutics
 
Marwan Fakih
Honoraria - Amgen
Consulting or Advisory Role - Bayer; BMS; Eisai; Merck; Mirati Therapeutics; Pfizer; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Agenus (Inst); Roche/Genentech (Inst); Verastem (Inst)